HBM Partners
Gavin MacGregor is an experienced finance professional specializing in global healthcare investments, currently serving as a Global Healthcare Investment Analyst & Portfolio Manager at HBM Partners AG since June 2017. Previously, Gavin MacGregor held positions as a Global Healthcare Investment Analyst at Martin Currie from 2012 to 2017 and as a Pharmaceuticals Equity Research Analyst at both Credit Suisse (2008-2012) and Lehman Brothers (2006-2008). Gavin MacGregor began their career at GSK as a Finance & Business Analyst through the Graduate Finance Programme from 2003 to 2006. Academic qualifications include a Bachelor of Science (BSc) with First Class Honours in Biomedical Sciences from The University of Manchester (1999-2002) and the ACMA designation from The Chartered Institute of Management Accountants, obtained between 2003 and 2006.
This person is not in any offices
HBM Partners
HBM Partners was founded in 2001 with the goal to invest in private and public emerging biopharma and other healthcare-related companies. HBM Partners has a team of experienced professionals to source, analyse and engage in investments in biopharma, medical devices and diagnostics industries. HBM Partners has a track-record of over 100 investments that resulted so far in significant value creation by more than 60 trade sales and IPOs since inception. HBM Partners is regulated by FINMA and advises SIX listed HBM Healthcare Investments and further specialised public and private equity investment products.